中图分类号:
R965
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] GRINBERG L T, HEINSEN H.Toward a pathological definition of vascular dementia [J] . J Neurol Sci, 2010, 299(1-2):136-138.
[2] KONG D, LIU Q, XU G, et al.Synergistic effect of tanshinone IIA and mesenchymal stem cells on preventing learning and memory deficits via anti-apoptosis, attenuating tau phosphorylation and enhancing the activity of central cholinergic system in vascular dementia[J] . Neurosci Lett, 2017, 637:175-181.
[3] YANG Y, WANG L, WU Y, et al. Tanshinol suppresses inflammatory factors in a rat model of vascular dementia and protects LPS-treated neurons via the MST1-FOXO3 signaling pathway[J] . Brain Res, 2016, 1646:304-314.
[4] PARK Y, JEONG Y H, TANTRY U S, et al. Effect of adjunctive dipyridamole to DAPT on platelet function profiles in stented patients with high platelet reactivity. The result of the ACCEL-DIP study[J] . Thromb Haemost, 2014, 112(6):1198-1208.
[5] ZHANG C, CHENG Y, WANG H, et al. RNA interference-mediated knockdown of long-form phosphodiesterase-4D (PDE4D) enzyme reverses amyloid-beta42-induced memory deficits in mice [J] . J Alzheimers Dis, 2014, 38(2):269-280.
[6] HERATIZADEH A, WERFEL T. Anti-inflammatory therapies in atopic dermatitis [J] . Allergy, 2016, 71(12):1666-1675.
[7] PULSINELLI W A, BUCHAN A M. The four-vessel occlusion rat model:method for complete occlusion of vertebral arteries and control of collateral circulation [J] . Stroke, 1988, 19(7):913-914.
[8] WU J G, WANG C M, GUO H B, et al. Novel phosphodiesterase 4 inhibitor chlorbipram enhanced memory deficits in AD rats and its mechanisms involved [J] . Chin Pharm J(中国药学杂志), 2015,50(11):947-953.
[9] WANG C M, CHENG Y F, WU J G, et al. The new PDE4 inhibitor Roflupram ameliorated cognitive deficits and neuroinflammation in a rat model of Alzheimer′s disease [J] . Chin Pharmacol Bull J(中国药理学通报), 2015,31(3):327-333.
[10] DAVEY D A. Alzheimer′s disease and vascular dementia:one potentially preventable and modifiable disease? Part Ⅱ:Management, prevention and future perspective[J] . Neurodegener Dis Manag, 2014, 4(3):261-270.
[11] CAO Y, GOU Z, DU Y, et al. Glutamatergic and central cholinergic dysfunction in the CA1, CA2 and CA3 fields on spatial learning and memory in chronic cerebral ischemia-Induced vascular dementia of rats[J] . Neurosci Lett, 2016, 620:169-176.
[12] JINGLONG T, WEIJUAN G, JUN L, et al. The molecular and electrophysiological mechanism of buyanghuanwu decoction in learning and memory ability of vascular dementia rats[J] . Braines Res Bull, 2013, 99:13-18.
[13] ARAI T. Effect of dipyridamole on arterial thrombosis development rate after replacement with the artificial valve[J] . Kyobu Geka, 1971, 24(8):601.
[14] ZIEGLER J W, IVY D D, FOX J J, et al. Dipyridamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus [J] . Am J Physiol, 1995, 269(2):473-479.
[15] GAMBOA A, ABRAHAM R, DIEDRICH A, et al. Role of adenosine and nitric oxide on the mechanisms of action of dipyridamole[J] . Stroke, 2005, 36(10):2170-2175.
[16] LUPI A, BUFFON A, FINOCCHIARO M L, et al. Mechanisms of adenosine-induced epicardial coronary artery dilatation[J] . Eur Heart J, 1997, 18(4):614-617.
[17] HEISTAD D D, MARCUS M L, GOURLEY J K, et al. Effect of adenosine and dipyridamole on cerebral blood flow[J] . Am J Physiol, 1981, 240(5):775-780.
[18] MENG C P. The clinical effect of aspirin enteric-coated tablets combined with dipyridamole treatment of cerebralthrombosis[J] . Guide China Med(中国医药指南), 2013, 24(2):43-44.
[19] SERITA T, FUKUSHIMA H, KIDA S. Constitutive activation of CREB in mice enhances temporal association learning and increases hippocampal CA1 neuronal spine density and complexity [J] . Sci Rep, 2017, 7:42528.
[20] D′HOOGE R, DE DEYN P P. Applications of the Morris water maze in the study of learning and memory[J] . Brain Res Rev, 2001, 36(1):60-90.
[21] VORHEES C V, WILLIAMS M T. Morris water maze:procedures for assessing spatial and related forms of learning and memory [J] . Nat Protoc, 2006, 1(2):848-858.
[22] AWANE M, ANDRES P G, LI D J, et al. NF-κB-Inducing kinase is a common mediator of IL-17-, TNF-α-, and IL-1β-induced chemokine promoter activation in intestinal epithelial cells [J] . J Immunol, 1999, 162(9):5337-5344.
[23] WANG Y, LU Y, CHAI J, et al. Y-27632, a Rho-associated protein kinase inhibitor, inhibits systemic lupus erythematosus [J] . Biomed Pharmacother, 2017, 88:359-366.
[24] COSTA G M, DE OLIVEIRA A P, MARTINELLI P M, et al.Demyelination/remyelination and expression of interleukin-1beta, substance P, nerve growth factor, and glial-derived neurotrophic factor during trigeminal neuropathic pain in rats[J] . Neurosci Lett, 2016, 612:210-218.
[25] ZHANG W, LI B, GUO Y, et al. Rhamnetin attenuates cognitive deficit and inhibits hippocampal inflammatory response and oxidative stress in rats with traumatic brain injury[J] . Cent Eur J Immunol, 2015, 40(1):35-41.
[26] MCCOLL B W, ALLAN S M, ROTHWELL N J. Systemic infection, inflammation and acute ischemic stroke [J] . Neuroscience, 2009, 158(3):1049-1061.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
广东省医学科学技术研究基金资助项目 (A2016557), 广东省职业病防治重点实验室课题(2017B030314152)
{{custom_fund}}